thiazoles has been researched along with mesalamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Eliakim, R; Karmeli, F; Ligumsky, M; Rachmilewitz, D; Simon, P | 1 |
Blades, S; Blake, DR; Chander, CL; Claxson, AW; Coumbe, A; Millar, AD; Morris, CJ; Panetta, J; Rampton, DS | 1 |
Harada, K; Inoue, T; Nagakura, N; Oketani, K | 1 |
Hussar, DA | 1 |
Abdel-Moty, SG; Abdu-Allah, HH; El-Awady, R; El-Shorbagi, AN | 1 |
Abdu-Allah, H; Al-Azawi, AM; El-Awady, R; El-Shorbagi, AN; Menon, V; Ramadan, W; Saleh, E; Tarazi, H; Vazhappilly, CG | 1 |
Abdu-Allah, HHM; El-Awady, R; El-Shorbagi, AA; Mansour, W; Menon, V; S Ramadan, W; Saleh, EM; Vazhappilly, CG | 1 |
Badalova, N; Davis, N; Navruzov, B; Osipova, S; Pazylova, D; Toychiev, A | 1 |
1 trial(s) available for thiazoles and mesalamine
Article | Year |
---|---|
Intestinal protozoa and helminths in ulcerative colitis and the influence of anti-parasitic therapy on the course of the disease.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiparasitic Agents; Blastocystis; Blastocystis Infections; Colitis, Ulcerative; Drug Therapy, Combination; Female; Giardia lamblia; Humans; Intestines; Male; Mesalamine; Middle Aged; Nitro Compounds; Prevalence; Thiazoles; Treatment Outcome; Young Adult | 2021 |
7 other study(ies) available for thiazoles and mesalamine
Article | Year |
---|---|
Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Calcimycin; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Imidazoles; Immunoglobulin E; Interleukin-1; Intestinal Mucosa; Mesalamine; Organ Culture Techniques; Platelet Activating Factor; Prednisolone; Sulfasalazine; Thiazoles | 1992 |
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.
Topics: Acetic Acid; Aminosalicylic Acids; Animals; Antioxidants; Butylated Hydroxytoluene; Colitis; Colitis, Ulcerative; Colon; Culture Techniques; Disease Models, Animal; Hydrocortisone; Luminescent Measurements; Male; Mesalamine; Rats; Rats, Wistar; Reactive Oxygen Species; Thiazoles | 1996 |
In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Topics: Animals; Arachidonate 5-Lipoxygenase; Benzothiazoles; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Humans; Hydroxyurea; Indomethacin; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mesalamine; Methacrylates; Neutrophils; Peritoneal Cavity; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Inbred F344; Sheep; Sulfasalazine; Thiazoles; Thromboxane B2; Thromboxane-A Synthase | 2001 |
New drugs 2002, part 1.
Topics: Amides; Aminosalicylic Acids; Anti-Ulcer Agents; Antipsychotic Agents; Bimatoprost; Cloprostenol; Cyclohexanes; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Galantamine; Glaucoma; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Mesalamine; Nateglinide; Nootropic Agents; Phenylalanine; Phenylhydrazines; Piperazines; Thiazoles; Travoprost | 2002 |
Design and synthesis of novel 5-aminosalicylate (5-ASA)-4-thiazolinone hybrid derivatives with promising antiproliferative activity.
Topics: Antineoplastic Agents; Cell Proliferation; Humans; MCF-7 Cells; Mesalamine; Models, Molecular; Neoplasms; Structure-Activity Relationship; Thiazoles | 2016 |
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
Topics: Apoptosis; Cell Movement; Cell Proliferation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; MAP Kinase Signaling System; MCF-7 Cells; Mesalamine; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; raf Kinases; ras Proteins; Thiazoles; Tumor Cells, Cultured | 2019 |
Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate-4-thiazolinone hybrid derivatives.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; HeLa Cells; Humans; MCF-7 Cells; Mesalamine; Thiazoles | 2020 |